Vermox Tablet, Chewable
Product Images NDC 50458-675

2 FDA label images from Janssen Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Vermox (NDC 50458-675). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Vermox 01)

Chemical Structure (Vermox 01)
Chemical structure diagram of mebendazole, the active ingredient in VERMOX 500 mg chewable tablets. The structure shows the arrangement of atoms and bonds specific to mebendazole's molecular composition.*
FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Principal Display Panel (500 mg Tablet Bottle Label)
Label for VERMOX chewable tablets containing 500 mg mebendazole. The label states the product is for oral use, prescription only, with 200 tablets per container. It includes storage instructions to keep below 30°C and to discard unused portions one month after first opening. Manufactured for Janssen Pharmaceuticals, Inc., with NDC 50458-675-20.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.